2019 | A second dose of a measles-mumps-rubella vaccine administered to healthy four-to-six-year-old children: a phase III, observer-blind, randomized, safety and immunogenicity study comparing GSK MMR and MMR II with and without DTaP-IPV and varicella vaccines co-administration | 김경효 | Article |
2007 | Comparison of growth and neuropsychological function after treatment for hematologic and oncologic diseases in monozygotic twins | 유경하 | Meeting Abstract |
2016 | Early Changes in the Serotype Distribution of Invasive Pneumococcal Isolates from Children after the Introduction of Extended-valent Pneumococcal Conjugate Vaccines in Korea, 2011-2013 | 김경효 | Article |
2021 | Emergence of serotype 10A-ST11189 among pediatric invasive pneumococcal diseases, South Korea, 2014-2019 | 김경효 | Article |
2017 | Immunogenicity and safety of a fully liquid DTaP-IPV-HB-PRP similar to T hexavalent vaccine compared with the standard of care in infants in the Republic of Korea | 김경효 | Article |
2018 | Long-term immunogenicity of an initial booster dose of an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with an inactivated, mouse brain-derived Japanese encephalitis vaccine | 김경효 | Article |
2007 | Neuroblastoma originating from extra-abdominal sites; Association with more favorable clinical features | 유경하 | Meeting Abstract |
2017 | Recent epidemiology of Streptococcus pneumoniae in nasopharynxes of Korean children with acute otitis media | 김경효 | Article |
2015 | Safety and immunogenicity of a freeze-dried, Vero cell culture-derived, inactivated Japanese encephalitis vaccine (KD-287, ENCEVAC((R))) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children: a phase III, multicenter, double-blinded, randomized trial | 김경효 | Article |
2023 | Twenty-Five Year Trend Change in the Etiology of Pediatric Invasive Bacterial Infections in Korea, 1996-2020 | 김경효 | Article |